Back to Journals » Drug Design, Development and Therapy » Volume 11

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Total article views   Abstract views HTML views PDF downloads Totals
8,802 Dovepress* 7,842 582+ 899 8,424
PubMed Central* 0 378 126 378
Totals 7,842 960 1,025 8,802
*Since 24 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar